Lite Strategy, Inc. — Director's Dealing 2018

Feb 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2018-02-22

Reporting Person: DRISCOLL FREDERICK W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-22	Options to purchase shares of common stock	$2.19	A	33333	Acquired	2028-02-22	Common Stock, par value $0.00000002 per share (33333)	Direct

Footnotes

F1: 20,000 options will vest ratably each month beginning March 1, 2018 over thirty-six months, and 13,333 of the options will vest ratably each month beginning March 1, 2018 over four months.